Literature DB >> 2048368

Effects of a screening program for hypertension in a community.

M Radice1, C Alli, F Avanzini, M Di Tullio, D Guiducci, G Mariotti, E Taioli.   

Abstract

The effect of a population screening for hypertension was assessed through a subsequent survey performed 1 year later. All the hypertensives identified at the first visit (239 subjects, 15.6% of the whole screened population) were invited for a re-examination: the adhesion rate was 84.5%. After the screening, a high proportion of subjects (74.7%) had contacted their physicians because of their blood pressure. The most common advice physicians gave was to have further measurements of blood pressure (72.8%). Laboratory tests were prescribed in 62 patients (41.1%), but a complete assessment of a target organ damage was carried out in few cases (1.9%). Only 19.5% of patients started a course of treatment during the year following the screening and no more than one-third of those with moderate to severe hypertension. Out of the 176 subjects showing other cardiovascular risk factors at the screening, only 12 reported they had modified their habits 1 year later. Our results suggest that a screening for hypertension, when performed without any liaison with other medical facilities, seems to have a poor impact on physicians' and patients' attitudes towards hypertension.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2048368

Source DB:  PubMed          Journal:  Acta Cardiol        ISSN: 0001-5385            Impact factor:   1.718


  2 in total

1.  The effect of screening for cardio-renal risk factors on drug use in the general population.

Authors:  Jarir Atthobari; Ron T Gansevoort; Sipke T Visser; Paul E de Jong; Lolkje T W de Jong-van den Berg
Journal:  Br J Clin Pharmacol       Date:  2007-12       Impact factor: 4.335

2.  Linking community-based blood pressure measurement to clinical care: a randomized controlled trial of outreach and tracking by community health workers.

Authors:  J Krieger; C Collier; L Song; D Martin
Journal:  Am J Public Health       Date:  1999-06       Impact factor: 9.308

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.